Defective Efficacy of Retinoic Acid Treatment in Patients with Metastatic Thyroid Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Defective Efficacy of Retinoic Acid Treatment in Patients with Metastatic Thyroid Carcinoma

Published:2006-10 Issue:10 Volume:16 Page:1025-1031
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Courbon F.¹,Zerdoud S.¹,Bastie D.¹,Archambaud Fr.²,Hoff M.¹,Eche N.¹,Berry I.¹,Caron Ph.³

Affiliation:

1. Department of Nuclear Medicine, University Hospital Toulouse Rangueil 1, Toulouse, France.

2. Department of Endocrinology and Metabolic Diseases, University Hospital of Limoges, France.

3. Department of Endocrinology and Metabolic Diseases, University Hospital of Toulouse Rangueil 1, Toulouse, France.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2006.16.1025

Reference24 articles.

1. A Systematic Review and Metaanalysis of the Effectiveness of Radioactive Iodine Remnant Ablation for Well-Differentiated Thyroid Cancer

2. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism

3. Surgical reintervention for differentiated thyroid cancer

4. Radionuclide diagnosis and therapy of thyroid cancer: Current status report

5. Combined chemotherapy with bleomycin, adriamycin, and platinum in advanced thyroid cancer

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress of plant-derived natural products in thyroid carcinoma;Frontiers in Chemistry;2024-01-10

2. Radionuclide Therapy of Thyroid Tumors;Nuclear Oncology;2022

3. Radionuclide Therapy of Thyroid Tumors;Nuclear Oncology;2022

4. Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer: Impaired sodium iodide symporter (NIS) expression owing to altered signaling pathway activity and intracellular localization of NIS;Theranostics;2021

5. Redifferentiation of radioiodine-refractory thyroid cancers;Endocrine-Related Cancer;2020-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3